Modern aspects of hepatology: liver steatosis and fibrosis through the prism of comorbidity in pediatric practice

Authors

DOI:

https://doi.org/10.15587/2519-4798.2021.232478

Keywords:

hepatic steatosis, hepatic fibrosis, non-alcoholic fatty liver disease, comorbid pathology, children and adolescents

Abstract

The relevance of the topic is dictated by the growing prevalence of hepatic steatosis and fibrosis in the pediatric population, which is due to an increase in the number of pathologies of various organs and systems, which may be accompanied by the development of these liver lesions.

The aim of the study: to analyze the data of modern sources of scientific literature regarding the prevalence and features of the course of pathology of various organs and systems, which is associated with the development of steatosis and liver fibrosis in the pediatric population.

Materials and methods. A systematic search of scientific was carried out using Web of Science, Scopus, PubMed, scientific bases with key words: «hepatic steatosis», «hepatic fibrosis», «non-alcoholic fatty liver disease», «comorbid pathology», «children and adolescents».

Conclusions. Currently, the number of children and adolescents who are diagnosed with steatosis and/or fibrosis of the liver is increasing in the world. In particular, the formation of this pathology is associated with the presence of metabolic syndrome and is associated with its main components, such as obesity, hypertension, disorders of carbohydrate and lipid metabolism. More and more studies indicate the role of non-alcoholic fatty liver disease, which is based on steatosis, as a comorbid pathology in systemic, cardiovascular, endocrine diseases, gastrointestinal tract pathology, and genetic disorders. Also, a number of drugs with steatogenic and fibrogenic effects on liver tissue have been established, which are widely used in pediatric practice. It is necessary to monitor the structural and functional state of the liver already in childhood and adolescence for adequate treatment of the underlying disease and prevention of the formation of comorbid pathology

Author Biographies

Larysa Strashok, Kharkiv Medical Academy of Postgraduate Education

MD, Professor, Head of Department

Department of Adolescent Medicine

Svetlana Turchyna, State Institution "Institute of Child and Adolescent Health of National Academy of Medical Sciences of Ukraine"

MD, Senior Researcher, Head of Department

Department of Endocrinology

Natalia Shevchenko, V. N. Karazin Kharkiv National University

MD, Head of the Department

Department of Pediatrics No. 2

Zalina Yeloyeva, Kharkiv Medical Academy of Postgraduate Education

MD, Professor, Head of Department

Department of Pediatrics

Olga Belousova, Kharkiv Medical Academy of Postgraduate Education

MD, Professor, Head of Department

Department of Pediatric Gastroenterology and Nutritiology

Olha Tsodikova, Kharkiv Medical Academy of Postgraduate Education

MD, Professor, Head of Department

Department of Outpatient Pediatrics

References

  1. Trefts, E., Gannon, M., Wasserman, D. H. (2017). The liver. Current Biology, 27 (21), R1147–R1151. doi: http://doi.org/10.1016/j.cub.2017.09.019
  2. Albanis, E., Friedman, S. L. (2001). Hepatic fibrosis. Pathogenesis and principles of therapy. Clinics in liver disease, 5 (2), 315–334. doi: http://doi.org/10.1016/s1089-3261(05)70168-9
  3. Bataller, R., Brenner, D. A. (2001). Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis. Seminars in Liver Disease, 21 (3), 437–452. doi: http://doi.org/10.1055/s-2001-17558
  4. Karanjia, R. N., Crossey, M. M. E., Cox, I. J., Fye, H. K. S., Njie, R., Goldin, R. D., Taylor-Robinson, S. D. (2016). Hepatic steatosis and fibrosis: Non-invasive assessment. World Journal of Gastroenterology, 22 (45), 9880–9897. doi: http://doi.org/10.3748/wjg.v22.i45.9880
  5. Alfani, R., Vassallo, E., De Anseris, A., Nazzaro, L., D’Acunzo, I., Porfito, C. et. al. (2018). Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. Children, 5 (12), 169. doi: http://doi.org/10.3390/children5120169
  6. Fang, Y.-L., Chen, H., Wang, C.-L., Liang, L. (2018). Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model.” World Journal of Gastroenterology, 24 (27), 2974–2983. doi: http://doi.org/10.3748/wjg.v24.i27.2974
  7. Anderson, E. L., Howe, L. D., Jones, H. E., Higgins, J. P. T., Lawlor, D. A., Fraser, A. (2015). The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLOS ONE, 10 (10), e0140908. doi: http://doi.org/10.1371/journal.pone.0140908
  8. Buznytska, O. V. (2014). Modern possibilities of non-invasive diagnosis of fibrosis at fatty liver disease in children and adolescents with obesity. Modern gastroenterology, 6, 19–24.
  9. Prokopowicz, Z., Malecka-Tendera, E., Matusik, P. (2018). Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology, 2018, 1–8. doi: http://doi.org/10.1155/2018/9465784
  10. Strashok, L. A., Buznytska, O. V., Meshkova, О. М. (2020). Indicators of lipid metabolism disorders in the blood serum of adolescents with metabolic syndrome. The Ukrainian Biochemical Journal, 92 (6), 137–142. doi: http://doi.org/10.15407/ubj92.06.137
  11. Pacifico, L., Bonci, E., Andreoli, G., Romaggioli, S., Di Miscio, R., Lombardo, C. V., Chiesa, C. (2014). Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutrition, Metabolism and Cardiovascular Diseases, 24 (7), 737–743. doi: http://doi.org/10.1016/j.numecd.2014.01.010
  12. Rutigliano, I., Vinci, R., De Filippo, G., Mancini, M., Stoppino, L., d’ Apolito, M. et. al. (2017). Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children. Nutrition, 36, 1–7. doi: http://doi.org/10.1016/j.nut.2016.10.017
  13. Daar, G., Serin, H. I., Ede, H., Husrevsahi, H. (2015). Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children. The Anatolian Journal of Cardiology, 16 (7), 524–528. doi: http://doi.org/10.5152/anatoljcardiol.2015.6279
  14. Pacifico, L., Di Martino, M., De Merulis, A., Bezzi, M., Osborn, J. F., Catalano, C., Chiesa, C. (2013). Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology, 59 (2), 461–470. doi: http://doi.org/10.1002/hep.26610
  15. Cohen, M. E., Deepak, P., Khanna, G., Samson, C. M. (2020). Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition, 72 (4), 574–578. doi: http://doi.org/10.1097/mpg.0000000000003023
  16. Pacifico, L., Martino, M. D., Anania, C., Andreoli, G. M., Bezzi, M., Catalano, C., Chiesa, C. (2015). Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. World Journal of Gastroenterology, 21 (15), 4688–4695. doi: http://doi.org/10.3748/wjg.v21.i15.4688
  17. Bedogni, G., Gastaldelli, A., Manco, M., De Col, A., Agosti, F., Tiribelli, C., Sartorio, A. (2012). Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children. Nutrition, Metabolism and Cardiovascular Diseases, 22 (2), 120–126. doi: http://doi.org/10.1016/j.numecd.2010.05.003
  18. Xanthakos, S. A., Jenkins, T. M., Kleiner, D. E., Boyce, T. W., Mourya, R., Karns, R. et. al. (2015). High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology, 149 (3), 623–634.e8. doi: http://doi.org/10.1053/j.gastro.2015.05.039
  19. Guo, Z., Li, M., Han, B., Qi, X. (2018). Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis. Digestive and Liver Disease, 50 (11), 1153–1162. doi: http://doi.org/10.1016/j.dld.2018.08.012
  20. Macut, D., Božić-Antić, I., Bjekić-Macut, J., Tziomalos, K. (2017). Management of endocrine disease: Polycystic ovary syndrome and nonalcoholic fatty liver disease. European Journal of Endocrinology, 177 (3), R145–R158. doi: http://doi.org/10.1530/eje-16-1063
  21. Ayonrinde, O. T., Adams, L. A., Doherty, D. A., Mori, T. A., Beilin, L. J., Oddy, W. H. et. al. (2016). Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. Journal of Gastroenterology and Hepatology, 31 (5), 980–987. doi: http://doi.org/10.1111/jgh.13241
  22. Carreau, A., Pyle, L., Garcia‐Reyes, Y., Rahat, H., Vigers, T., Jensen, T. et. al. (2019). Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS‐HS index). Clinical Endocrinology, 91 (4), 544–552. doi: http://doi.org/10.1111/cen.14062
  23. Mushannen, T., Cortez, P., Stanford, F. C., Singhal, V. (2019). Obesity and Hypogonadism – A Narrative Review Highlighting the Need for High-Quality Data in Adolescents. Children, 6 (5), 63. doi: http://doi.org/10.3390/children6050063
  24. Stancampiano, M. R., Lucas-Herald, A. K., Russo, G., Rogol, A. D., Ahmed, S. F. (2019). Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach. Hormone Research in Paediatrics, 92 (4), 215–228. doi: http://doi.org/10.1159/000504670
  25. Parkhomenko, L. K., Strashok, L. A., Turchyna, S. I., Yeloyeva, Z. V., Klymenko, T. M., Kosovtsova, H. V. et. al. (2021). Mechanisms of hepatic steatosis formation in adolescent boys with hypoandrogenism. Reproductive Endocrinology, 57, 79–83. doi: http://doi.org/10.18370/2309-4117.2021.57.79-83
  26. Chalasani, N., Amacher, D. (2014). Drug-Induced Hepatic Steatosis. Seminars in Liver Disease, 34 (2), 205–214. doi: http://doi.org/10.1055/s-0034-1375960
  27. Satapathy, S. K., Kuwajima, V., Nadelson, J., Atiq, O., Sanyal, A. J. (2015). Drug-induced fatty liver disease: An overview of pathogenesis and management. Annals of Hepatology, 14 (6), 789–806. doi: http://doi.org/10.5604/16652681.1171749
  28. Miele, L., Liguori, A., Marrone, G., Biolato, M., Araneo, C., Vaccaro, F. G. et. al. (2017). Fatty liver and drugs: the two sides of the same coin. European review for medical and pharmacological sciences, 21 (1 Suppl), 86–94.
  29. Goldmuntz, E. A., White, P. H. (2006). Juvenile Idiopathic Arthritis: A Review for the Pediatrician. Pediatrics in Review, 27 (4), e24–e32. doi: http://doi.org/10.1542/pir.27-4-e24
  30. Salliot, C., van der Heijde, D. (2008). Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Annals of the Rheumatic Diseases, 68 (7), 1100–1104. doi: http://doi.org/10.1136/ard.2008.093690
  31. Valentino, P. L., Church, P. C., Shah, P. S., Beyene, J., Griffiths, A. M., Feldman, B. M., Kamath, B. M. (2014). Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 20 (1), 47–59. doi: http://doi.org/10.1097/01.mib.0000436953.88522.3e

Downloads

Published

2021-05-31

How to Cite

Strashok, L., Turchyna, S. ., Shevchenko, N., Yeloyeva, Z., Belousova, O. ., & Tsodikova, O. (2021). Modern aspects of hepatology: liver steatosis and fibrosis through the prism of comorbidity in pediatric practice. ScienceRise: Medical Science, (3(42), 50–55. https://doi.org/10.15587/2519-4798.2021.232478

Issue

No. 3(42) (2021)

Section

Medical Science

License

Copyright (c) 2021 Larysa Strashok, Svetlana Turchyna, Natalia Shevchenko, Zalina Yeloyeva, Olga Belousova, Olha Tsodikova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.